BioAge Labs, Inc.
BIOA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Operating Activities | – | – | – |
| Net Income | -$71,109 | -$63,854 | -$39,722 |
| Dep. & Amort. | $167 | $162 | $129 |
| Deferred Tax | $0 | $0 | $0 |
| Stock-Based Comp. | $6,979 | $3,016 | $2,540 |
| Change in WC | $11,176 | $6,710 | $795 |
| Other Non-Cash | $1,265 | $16,604 | $77 |
| Operating Cash Flow | -$51,522 | -$37,362 | -$36,181 |
| Investing Activities | – | – | – |
| PP&E Inv. | -$366 | -$166 | -$103 |
| Net Acquisitions | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$100 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 |
| Investing Cash Flow | -$366 | -$266 | -$103 |
| Financing Activities | – | – | – |
| Debt Repay. | -$6,000 | $35,000 | $2,500 |
| Stock Issued | $221,619 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 |
| Other Fin. Act. | -$4,420 | -$59 | -$1 |
| Financing Cash Flow | $381,199 | $34,941 | $2,499 |
| Forex Effect | $81 | $0 | $246 |
| Net Chg. in Cash | $329,392 | -$2,687 | -$33,539 |
| Supplemental Information | – | – | – |
| Beg. Cash | $24,957 | $27,644 | $61,183 |
| End Cash | $354,349 | $24,957 | $27,644 |
| Free Cash Flow | -$51,888 | -$37,528 | -$36,284 |